Jump to content

JOIN THE DISCUSSION!

Want to join the discussions?

Sign up for a free membership! 

If you are a member already, log in!

(lost your password? reset it here)

99nicu.org 99nicu.org
  • Latest Blog Entries

         2 comments
      Hi
      there seem to be enough evidence about the lack of beneficial effect of treatment of the PDA!
      The approach to a hemodinámica significant ductus has changed significantly in the last 10 years. 
      Years ago we weee so obsessed that indocin prophylaxis was standard in many NICUs and early treatment became standard across the board. 
      I remember going to Dr Clayman  PDA lecture at PAS where the PDA was seen as a demon
      many babies had  been exposed to surgical ligation with a known consecuentes of a surgery on a small premie baby 
      since William Benitez published his meta analysis about PDA there has been a definitive change in some centers on how to approach it and some has gone away from early treatment and surgery 
      there are other centers that continue to ignore the Trent and treat the PDA like we used to 10 years ago.
      we I have noted in my practice is that regardless of the PDA size; baby that are on Mechanical ventilation after 7-10 days we give a course of tapering Decadeon (DATRT) and they get extubated
      i Belice fluid/sedation/lung protective strategy and steroids when use appropriately will result in better outcomes for our micro premie of 22-26 weeks
      whats are you doing in your practice?
      thanks
       
       
         1 comment
      Had a chance to attend #TEIBIO - 
      Transference (of knowledge Entrepreneurship ) & Innovation in Biotech .
      inspirational talk on rare diseases awareness day and topics were bringing hope to paediatrics #nicu: by address solutions to Neonatal Congenital Heart #CHD ❤️and better tolerance heart transplant.
      - 💡Crazy scienceco-founder Dr. Beatriz Salvador shows us how her team have found a non-invasive treatment for Congenital Diaphragmatic Hernia. 
      They were able the hole in CDH by regulating the immune system. 
      Have had 75%success rate and animal models have shown low toxicity.
      Currently recognized as an orphan drug EU - finalize animal model trial in a non-rodent model. 
      Hopes to begin clinical trials in 2025 with the esteem collaboration of Dra. Mayte Vallejo, del Instituto para la Investigación Biomédica del Hospital Universitario La Paz de Madrid (IDIPAZ) y paciente advocacy association «La vida con Hernia Diafragmática Congénita» located in Mérida, Spain.
      Crazy Science & Business S.L.   
      https://crazyscience.es

       
       
      Rafael C. Rocha   THYTECH founded a start-up to find a solution to avoid rejection in❤️ transplant in babies. Here the team are using an infant's timus cell to avoid rejection.
      https://es.linkedin.com/company/thytech
       
      Thanks to Carlos Cosculluela Chocarro for the shout-out. @FundacionDRO AsBioMad 
       
         0 comments
      The 99nicu.org web site is built on the Invision Power Board software. 
      In the next version (v5) there will be a major overhaul of the user interface, allowing for an even better way of presenting and browsing content here.
      You can get a sneak preview in the video below (a bit techy, but still )
       
         1 comment
      I don’t need to expand on how Internet and social media have shifted the paradigm for professional discussion. You know this!
      Painful it is, but I wanted to share that I have decided to close my Twitter/X account. I will miss you tweeps. But... see you soon elsewhere!
      I started to build a network on Twitter in 2009, exploring this new channel for communication about research and medicine. Twitter was different then, compared to what X has become. In the earlier years, Twitter impersonated open, high-level and cross-professional discussions. Despite different opinions shared, the feed was a friendly gathering. If you posted something seemingly controversial (or something not at all controversial about Covid-19, liberal democracy values, suffering among immigrants, or aggressive warfare), people commented in a respectful manner. You did not get a load of automated bot replies (from "verified accounts" with like ~10 followers) telling you were a moron and should XYZ!
      Importantly, #NeoTwitter, #NeoEBM and #foamneo all grew into valuable resources. I am so grateful for connecting with you and other wonderful people there. It has indeed enriched my professional life, and often made me think twice.
      With X and the new leadership by Musk et al (btw, is there even an “al”?), I have simply taken the consequence of not compromising with my values. That’s why I will delete my X account soon, after saying good bye to comrades there. The principal reason is that I don’t want to contribute to a communication platform where hate speech, conspiracy theories, and fake news is given this much space. The world of today is complicated enough as it is.
      Although my own feed is still pretty OK, I feel that sharing a communication platform with the “dark side” (and don’t underestimate the force of it), implies that my presence there, as a person and as a professional, legitimate the bad stuff. In fact, this might even be an intentional business strategy of the X management team.
      There is certainly some “alternative cost” to rebuild a neonatal network on a new platform. But I am fine with that. For myself, this is a step worth taking to get rid off the feeling that I am also, to some symbolic extent, feeding the trolls on X.
      For the time being, I will stick to LinkedIn, while hoping to rebuild a network feed on our NICUVERSE Mastodon-server and/or on Bluesky. So, might see you there
      And of course, maybe the future holds a renaissance for 99nicu.org with its older-school web site-based discussions.
      Please note that this is a personal decision and about my own Tw/X account. However, within the 99nicu Team, we are also discussing an X-it strategy, but we need to make sure we have the organization's best interest in mind. And, with our upcoming conference, we may choose to keep the 99nicu account up and running to for sharing the word about our conference plans. After all, #NeoTwitter is still a great place for reaching out.
      Thanks to the Verge for making the graphics illustrating this post

  • Upcoming Events

    • 11 September 2024 07:00 AM Until 13 September 2024 04:00 PM
      0  
      The upcoming ECPM 2024 is organized by esteemed European Association of Perinatal Medicine (EAPM). This congress will provide physicians, researchers, trainees and students an excellent opportunity to discuss and explore a wide range of crucial topics in perinatal medicine.
      Stay tuned for more updates on the programme and registration at ecpmcongress.eu
    • 12 September 2024
      0  
      Certification in Neonatal Therapy 2021
      Requirements for Certification in Neonatal Therapy include Qualified and Licensed Therapist who is holding Elite membership of Association of Neonatal Therapists. He/she should have completed 40 hours of training in neonatal therapy/care (direct teaching and or webinar), upto 350 hours of Direct Mentoring in Affiliated Set up. Kindly use following checklist for your reference.
      1) Completed Post Graduation (Final year student can apply) 
      2) Active License
      3) Elite Member of Association of Neonatal Therapists
      4) Active professional membership of ANT
      5) 40 hours of training in neonatal therapy (direct teaching / online webinar) ...scrutiny about validity of the courses will be done.
      6 ) 350 + hours of Direct mentoring in affiliated set up - after examination 
      Cost Rs. 40000/- (Approximately)
      7) Exam fees INR 1000/- Rs
      😎 TRAIN Workshop completion (during mentorship)
    • 19 September 2024 06:00 AM Until 20 September 2024 12:30 PM
      0  
      The purpose of this workshop is to increase the skills on the use of NAVA ventilation and lung ultrasound (LUS) in the NICUs. This is the first time we combine both modalities to offer the participants two new ways to enlarge their treatment and diagnosis options. Some previous experience and theoretical knowledge of NAVA and LUS as well as suitable equipment is of advantage (Servo-i or Servo-n ventilators, US machine with a LUS compatible probe).

      The workshop will focus on
      - interpretation of the Edi signal - interpretation of LUS findings
      - utilization of the monitoring capabilities - making a diagnosis using LUS
      - individualization of the treatment - implementation of LUS in the NICU
      - implementation of NAVA in the NICU

      We aim to get together a group of NAVA and LUS users at the same level of experience. We encourage you to participate as a team of both doctor and nurse participants.
      The course includes both theory sessions and bedside teaching with the patients on NAVA ventilation in the NICU. LUS examinations will also be performed with NICU patients. Each participant is invited to present a patient case which has a teaching point on either NAVA or LUS.

      TIME AND PLACE
      The course will be held in September 19-20, 2024 in Turku, Finland by Dr Hanna Soukka, Professor Liisa Lehtonen, Dr Frank Fuchs and Dr Nadya Yousef at the Turku University Hospital.
      REGISTRATION AND ACCOMODATION
      You can apply for the course by contacting Hanna Soukka at hanna.soukka@utu.fi. The registration fee is 800 € + taxes including the lunches and refreshments during the workshop. The participants are responsible to arrange their travelling and accommodation by themselves at their own expense. For more information, contact Dr Hanna Soukka, hanna.soukka@utu.fi

      Turku University Hospital
      Majakkasairaala, Savitehtaankatu 5
      Lecture hall Bengtskär, 3rd floor
      Turku NAVA 2024.pdf
    • 25 September 2024 06:00 AM Until 27 September 2024 11:00 AM
      0  
      Objectives
      This seminar will provide an understanding of the pharmacological principles known as evidence-based pharmacology that will translate into daily clinical practice and provide participants (neonatologists, pediatricians, pharmacists, nurses, pharmacologists, pharmacometricians, and many others) interested in the field with the latest updates. As a novelty, participants will also be invited to present and discuss interesting pharmacological cases with the faculty and each other.
    • 02 October 2024 Until 03 October 2024
      0  
      Please join us at FICare 2024, the 7th International Family Integrated Care Conference, Glasgow, UK & Virtual, October 2-3rd, 2024.
      FICare 2024 brings together international neonatal families, researchers and clinical teams to share the latest research, innovations and practical approaches to put families at the heart of neonatal care.
      Key themes for FICare 2024 include:
      Personalising FICare – does one size fit all? Communication with families – what works, what doesn’t Music and signing in the NICU Parent-led co-design and innovation in FICare Implementing FICare: regional and national approaches Making FICare a strategic priority: Parent & Political Advocacy Sustaining FICare: getting past the 3C’s Culture, Covid & Capacity  
      For more details including our international expert faculty please visit:
      https://cfsevents.eventsair.com/7th-international-family-integrated-care-conference-2024/
      Abstract submission is now open until 31st July 2024:
      https://cfsevents.eventsair.com/7th-international-family-integrated-care-conference-2024/abstracts
      Early bird registration available until Tuesday 3rd September 2024.
      For more information and any questions, please contact:
      terrie@cfsevents.co.uk
    • 02 October 2024
      0  
      N3 (Neonatal Nutrition Network - https://neonatalnutritionnetwork.org/)  is arranging the next annual meeting on 2 October 2024!
      Join a very exciting programme covering many different areas on neonatal nutrition and growth.
      The day includes several interesting lectures and afternoon workshops. In response to previous feedback the workshops will run twice in the afternoon so as to maximise the chances for attendance for our delegates.
      The meeting will be held in a hybrid format and all relevant information with details on registration can be found on the attached flyer. There is still time for the early bird fees  
      N3 24 autumn flyer programme.pdf
    • 03 October 2024 Until 05 October 2024
      0  
      Objectives  
      IPOKRaTES seminars provide high quality postgraduate education which enables professionals to keep abreast of the most recent developments and offer participants the opportunity to discuss clinical problems or scientific issues personally with international experts.
      This program will focus on:
      1. Discuss current controversies related to nutrition of the neonate such as   donor milk use, parenteral nutrition strategies, enteral nutrition composition   and advancement, microbial therapeutics and optimization of breast feeding.
      2. Appraise recent research related to optimization of nutrition for preterm   infants.
      3. Discuss implementation strategies for scientifically based nutritional guidelines.
      4. Summarize recent advances in technology for evaluation of intestinal function.
      5. Generate novel research roadmaps for early recognition and prevention of   adverse outcomes such as “Necrotizing Enterocolitis”, “Bronchopulmonary   Dysplasia,”, Retinopathy of Prematurity, Late Onset Sepsis and Growth Failure   in preterm infants using artificial intelligence/machine learning and multiomic   integration.
  •  

    99nicu Society Members - check out the Society Lounge here!

  • Your Neonatology Forum!

    Welcome to 99nicu, the #1 web community for neonatal staff!

    Become a member free of charge, to get and give advice, start your own blog and enjoy benefits!

    :) 

  • Latest Posts

    • This may be offered to parents, but the parents and the physician should make the decision together.
    • Thank you all for very valuable input that also gives us and especially the nurse in question who knows this and is the only one so far doing it motivation to proceed with this, trying to educate others. We´ve tried US guided UVC and UAC on occasion and could definately get better there. We still x-ray for position. Really grateful for your help!
    • Hi Pontus, agree with all comments before. we have lots of experience with US-guided central lines, less with peripheral (but some) and arterial lines. It is only done by doctors at our department. We use both approaches: out-of-plane and in-plane. Regarding the canulas: we use both, most commonly we use the neoflon/venflon. but personally I think the one on the left is superior as it is a lot sharper and has less issues with not being able to puncture the skin or vessels adequately. Though my favourite is the Jelco iv. Once you use it you dont want to go back - especially in kids with thicker/tougher skin. Although it needs some practice as it does not have the "wings" of the neoflon which allows for a better grip. We have some experience with the guidewire, it comes in handy at times, but needs some practice to handle optimally. Although aimed at adults, I think this article has lots of good practical advice: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9886173/  or also here https://www.pocus101.com/ultrasound-guided-peripheral-iv-insertion-placement-and-access-made-easy/
    • It is individual practice and case by case scenario, but i will recommond screening for PID in the neonatal period if facilities are there. 
    • Hi, Currently work in Melbourne, Australia. US guided cannulation is being used with increasing frequency in paediatrics and anaesthesia.  My experience with neonates is more limited, I've only really done it with supervision.  As Tamimi states, the learning curve is steep- it's like going back to square one all over again.  It's harder in neonates than with children I think, I feel like I need an extra arm.  You do need a longer cannula, with the shorter one you run out of road.  On the flipside, a 3cm line should stay in longer than a 1.9cm line. Unrelated to ultrasound- we have on occasion used a guidewire to upgrade a 1.4cm line, or a 26g cannula to a 24g 3cm cannula.
    • Thank you for bringing up the topic that is very dear to me. Yes we routinely use ultrasound for ECC insertion and peripheral arterial line. We use every now and then if the nurses are not able to secure a peripheral access.it’s done by a doctor in the unit that is interested in vascular access. Trainees are still learning it and it’s very steep learning curve although looks in theory very simple.     In regards to the access that you’ve posted. Yes I have experience with it with it. It was not good. In theory it sounds very appealing, but in reality, the metal cannula is soft and kind of pliable. I noticed that once I prick the skin and I have the needle under the skin and I tried to maneuver it left and right it bends I think because of the length that makes it bendable . But that’s my personal experience. I haven’t read any literature about this. I hope this helps.
    • Dear all! Do you on your ward routinely use US-guidance for putting PVC, PICC-line in and if so do only doctors do it and/or nurses? Experience? Also, any experience on so called "deep access canula" 32 mm vs 19 mm. Do they last longer? Any problems?
    • Clinical study using Monivent Neo100 published in Resuscitation A clinical study showing significant improvement of the quality of manual ventilation of newborns in need of respiratory support using the Neo100 was finalized last year. The clinical paper on the results from this trial has now been accepted to be published in the highly renowned journal Resuscitation and is available at resuscitationjournal.com.  The clinical study, “Optimization of manual ventilation quality using respiratory function monitoring in neonates: A two-phase intervention trial”, was conducted by Dr Robyn Dvorsky and the research team led by Dr Michael Wagner at the Medical University Hospital in Vienna. The results of the clinical study, including 90 newborns, show that the use of Neo100 significantly increased the quality of ventilations by a higher percentage (53.7%) occurring within a target volume range in the group with visible monitor and feedback compared to the control group without feedback (37.3%). Furthermore, excessive tidal volumes, which have been previously associated with an increased risk of brain injury, as well as mask leakage, which may impact the ability to deliver air to the baby’s lungs, could be significantly reduced. The equipment was used for newborn resuscitation in the delivery room and during elective intubation in the neonatal intensive care unit. The results from the trial were first presented at the Pediatric Academic Societies (PAS) annual meeting in Washington in May 2023. Link to the publication here: https://bit.ly/3AsUkJP
    • If we use special care milk formula for premature babies then as per my opinion no need of MCT oil or olive oil.
    • Great editorial and I agree the final words that Generally speaking, I am less in favor of testing for disease that lacks preventive or therapeutic treatments. I am not too much into this domain of rare diseases myself, but my clinical experience is that infants/children with really rare disorders, families are often glad to get a "name" for the disease but can also be disappointed to learn there is not much to offer except more general support (and management of symtoms) I see a risk this kind of screening would mostly be used to satisfy a well-resourced middle class (that would also cover the testing costs themselves), and become another "reassurance thing" those families do, to further dig into the good health of their newborn, along the lines what is "nice to know" rather than what is a "need to know"
×
×
  • Create New...